Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings

Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings

Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter...

Full description

Bibliographic Details
Main Authors: Daphne E. Boucherie, Liesbeth Reneman, Henricus G. Ruhé, Anouk Schrantee
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:NeuroImage: Clinical
Subjects:
Major Depressive Disorder
SSRI
SNRI
(es)ketamine
1H-MRS
Glutamate
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158223002085

Internet

http://www.sciencedirect.com/science/article/pii/S2213158223002085

Similar Items